Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB

Authors:

Abstract
No abstract available
Funding Information
  • National Institute for Health and Care Research

This publication has 44 references indexed in Scilit: